Three questions about the Franco-Austrian Valneva vaccine, which has just been authorized by the EU

The laboratory, based in Nantes, had carried out the first human trials of its vaccine candidate in December 2021. It is now the first serum approved in Europe using traditional inactivated virus technology, a more traditional technology than that of the virus. messenger RNA. “It’s a technology that’s been used for over 70 years for … Read more